抗結核治療における腹部結核患者の肝臓損傷と適応のパターン:前向きなコホート研究
Abhishek Kumar1, Ramesh Kumar1, Vijay Kumar2
1Department of Gastroenterology, All India Institute of Medical Sciences, Patna, India.
Journal of clinical and experimental hepatology
|September 2, 2025
まとめ
抗結核治療を受けている腹部結核の患者はしばしば肝臓損傷を発症しますが,多くは肝臓の適応により自発的に回復します. アルブミンとビタミンDのレベルが低いと,薬による肝損傷の進行が予測されます.
科学分野:
- ヘパトロジー
- 感染症
- 胃腸内科
背景:
- 肺の外結核,特に腹結核 (ATB) は,抗結核治療 (ATT) 中の薬物誘発性肝損傷 (DILI) のリスクを伴う.
- 肝臓適応 (HA) は,ATTにもかかわらず,一部の患者の肝臓機能検査 (LFT) の自発的な正常化につながる可能性があります.
- ATTを受けたATB患者における肝損傷パターン,HA,およびその予測因子に関する予見データは限られている.
研究 の 目的:
- ATTを受けたATB患者における肝損傷の発生率とパターンを評価する.
- ATB患者の肝臓適応 (HA) の発生と予測要因を評価する.
- この集団における薬物誘発性肝損傷 (DILI) の進行を予測する要因を特定する.
主な方法:
- 予期的なコホート研究で,ATB患者140人が正常なLFTと診断されました.
- 標準の4薬のATTでのLFTの連続監視
- DILIとHAの予測要因を特定するための多変数ロジスティック回帰分析.
主要な成果:
- 患者の50. 7%がLFT異常を経験し,27. 1%がDILIの基準を満たした.
- LFT異常の46. 4%が自発的に解消し,HAを示した.
- 血清アルブミンの低下とビタミンD欠乏は,DILIの進行を予測する独立した要因であり,DILIは主に治療の最初の8週間以内に発生した.
結論:
- LFTの異常はATTを受けたATB患者で頻繁に見られるが,HAはほぼ半分で自発的に解消する.
- 低アルブミン血症とビタミンD欠乏症は,DILIの進行を予測する重要な要因であり,LFTの注意深いモニタリングの必要性を強調しています.
- これらの予測因子の早期発見は,ATB患者のDILIリスクを軽減するための積極的な管理戦略を導くことができます.
関連する概念動画
01:28Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
01:29Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
01:31Pulmonary Tuberculosis III
439
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
439
01:26Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
01:28Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
01:26Diseases of the Liver and Gallbladder
965
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
965